101 related articles for article (PubMed ID: 12355779)
1. [Islet cell antibodies].
Kobayashi T
Nihon Rinsho; 2002 Aug; 60 Suppl 8():390-4. PubMed ID: 12355779
[No Abstract] [Full Text] [Related]
2. [Autoantibodies against GAD, GAD65 and IA-2].
Tsujii S
Nihon Rinsho; 2002 Aug; 60 Suppl 8():395-400. PubMed ID: 12355780
[No Abstract] [Full Text] [Related]
3. [Prevalence of anti-GAD autoantibodies in Tunisian children with type 1 diabetes].
Elkadhi A; Khelifi N; Abid A; Nagati K; Jenhani F; Ben Rayana MC
Tunis Med; 2002 May; 80(5):281-5. PubMed ID: 12534034
[TBL] [Abstract][Full Text] [Related]
4. Prediction and prevention of type I diabetes.
Eisenbarth GS; Gianani R; Pugliese A; Verge CF; Pietropaolo M
Transplant Proc; 1994 Apr; 26(2):361-2. PubMed ID: 8171463
[No Abstract] [Full Text] [Related]
5. Antibodies as predictors of type 1 diabetes.
Wilkin TJ
Compr Ther; 1991 Jul; 17(7):3-10. PubMed ID: 1742966
[No Abstract] [Full Text] [Related]
6. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
Bieg S; Seissler J; Scherbaum WA
Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923
[No Abstract] [Full Text] [Related]
7. [Clinical significance of islet-cell antibodies (ICA) for prevention of type 1 diabetes].
Kobayashi T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():25-9. PubMed ID: 12386974
[No Abstract] [Full Text] [Related]
8. Prediction and prevention of Type 1 diabetes mellitus.
Zhang L; Eisenbarth GS
J Diabetes; 2011 Mar; 3(1):48-57. PubMed ID: 21073664
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in Type 1 diabetes.
Schmidt KD; Valeri C; Leslie RD
Clin Chim Acta; 2005 Apr; 354(1-2):35-40. PubMed ID: 15748597
[TBL] [Abstract][Full Text] [Related]
10. [Predictive, diagnostic, and prognostic value of the anti-GAD antibody].
Takahashi K; Satoh J
Nihon Rinsho; 2002 Sep; 60 Suppl 9():19-24. PubMed ID: 12386973
[No Abstract] [Full Text] [Related]
11. [Anti GAD (glutamic acid decarboxylase) antibody].
Yamanouchi T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():555-7. PubMed ID: 16149576
[No Abstract] [Full Text] [Related]
12. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes.
Striano P; Perruolo G; Errichiello L; Formisano P; Beguinot F; Zara F; Striano S
Ann Neurol; 2008 Jan; 63(1):127-8. PubMed ID: 17167787
[No Abstract] [Full Text] [Related]
13. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
Thivolet C
Journ Annu Diabetol Hotel Dieu; 1992; ():165-71. PubMed ID: 1495236
[No Abstract] [Full Text] [Related]
14. [Early diagnosis of diabetes mellitus with the anti-GAD test].
Jungmann E
Fortschr Med; 1994 Dec; 112(35-36):8-9. PubMed ID: 7843686
[No Abstract] [Full Text] [Related]
15. [Islet cell antibody (ICA)].
Kobayashi T
Nihon Rinsho; 1997 Nov; 55 Suppl():328-32. PubMed ID: 9434489
[No Abstract] [Full Text] [Related]
16. [Multicenter randomized trial on prevention of type 1 diabetes].
Kobayashi T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():48-51. PubMed ID: 12386978
[No Abstract] [Full Text] [Related]
17. [Autoantibodies against GAD and GAD65].
Tsujii S
Nihon Rinsho; 1998 Jan; 56 Suppl 3():190-5. PubMed ID: 9513413
[No Abstract] [Full Text] [Related]
18. Combined antibody screening for improved prediction of IDDM--modern strategies.
Roll U; Ziegler AG
Exp Clin Endocrinol Diabetes; 1997; 105(1):1-14. PubMed ID: 9088889
[No Abstract] [Full Text] [Related]
19. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
20. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies.
Marshall MO; Høyer PE; Petersen JS; Hejnaes KR; Genovese S; Dyrberg T; Bottazzo GF
J Autoimmun; 1994 Aug; 7(4):497-508. PubMed ID: 7980851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
